Efficient radiosynthesis and preclinical evaluation of [ 18 F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging
Journal of Labelled Compounds and Radiopharmaceuticals · 2020-03 · 63 (3) · 144-150
DOI: 10.1002/jlcr.3827 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, online erschienen am 29.01.2020. Verfasst von Thomas A Singleton und 8 weiteren Autor:innen. Beteiligte Einrichtung: McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Quebec, Canada. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Receptor, trkB. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Health Canada, Fondation Brain Canada, Alzheimer Society.
Abstract (Originalsprache)
Herein we report an efficient radiolabeling of a 18 F‐fluorinated derivative of dual inhibitor GW2580, with its subsequent evaluation as a positron emission tomography (PET) tracer candidate for imaging of two neuroreceptor targets implicated in the pathophysiology of neurodegeneration: tropomyosin receptor kinases (TrkB/C) and colony stimulating factor receptor (CSF‐1R). [ 18 F]FOMPyD was synthesized from a boronic acid pinacolate precursor via copper‐mediated 18 F‐fluorination concerted with thermal deprotection of the four Boc groups on a diaminopyrimidine moiety in an 8.7±2.8% radiochemical yield, a radiochemical purity >99%, and an effective molar activity of 187±93 GBq/μmol. [ 18 F]FOMPyD showed moderate brain permeability in wild‐type rats (SUV max = 0.75) and a slow washout rate. The brain uptake was partially reduced (ΔAUC 40–90 = 11.6%) by administration of the nonradioactive FOMPyD (up to 30 μg/kg). In autoradiography, [ 18 F]FOMPyD exhibits ubiquitous distribution in rat and human brain tissues with relatively high nonspecific binding revealed by self‐blocking experiment. The binding was blocked by TrkB/C inhibitors, but not with a CSF‐1R inhibitor, suggesting selective binding to the former receptor. Although an unfavorable pharmacokinetic profile will likely preclude application of [ 18 F]FOMPyD as a PET tracer for brain imaging, the concomitant one‐pot copper‐mediated 18 F‐fluorination/Boc‐deprotection is a practical technique for the automated radiosynthesis of acid‐sensitive PET tracers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Quebec, Canada.
- Department of Neurology and Neurosurgery, McGill University, Quebec, Canada.
- Department of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, Alberta, Canada.
- Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging, Douglas Mental Health University Institute, Quebec, Canada.
ORCID-Profile: Thomas A Singleton, Hussein Bdair, Justin J Bailey, Pedro Rosa-Neto, Ralf Schirrmacher, Alexey Kostikov
Förderung
- Health Canada
- Fondation Brain Canada
- Alzheimer Society
Zitieren
APA
Singleton, T. A., Bdair, H., Bailey, J. J., Choi, S., Aliaga, A., Rosa-Neto, P., Schirrmacher, R., Bernard-Gauthier, V., & Kostikov, A. (2020). Efficient radiosynthesis and preclinical evaluation of [ 18 F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging. Journal of Labelled Compounds and Radiopharmaceuticals, 63(3), 144-150. https://doi.org/10.1002/jlcr.3827
Vancouver
Singleton TA, Bdair H, Bailey JJ, Choi S, Aliaga A, Rosa-Neto P, et al. Efficient radiosynthesis and preclinical evaluation of [ 18 F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging. Journal of Labelled Compounds and Radiopharmaceuticals. 2020;63(3):144-150. doi:10.1002/jlcr.3827
BibTeX
@article{Singleton2020,
author = {Singleton, Thomas A and Bdair, Hussein and Bailey, Justin J and Choi, Sangho and Aliaga, Arturo and Rosa-Neto, Pedro and Schirrmacher, Ralf and Bernard-Gauthier, Vadim and Kostikov, Alexey},
title = {Efficient radiosynthesis and preclinical evaluation of [ 18 F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2020},
volume = {63},
number = {3},
pages = {144--150},
doi = {10.1002/jlcr.3827}
}
EUVIMED